- Home
- CLDX vs CET Comparison
CLDX vs CET Comparison
Compare CLDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | CET |
|---|---|---|
| Founded | N/A | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.6B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | CET |
|---|---|---|
| Price | $32.47 | $53.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.60 | N/A |
| AVG Volume (30 Days) | ★ 677.8K | 38.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | N/A |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $18.56 | $45.77 |
| 52 Week High | $35.83 | $54.28 |
Technical Indicators
Market Signals| Indicator | CLDX | CET |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 58.03 |
| Support Level | $31.65 | $50.64 |
| Resistance Level | $35.18 | $53.88 |
| Average True Range (ATR) | 1.49 | 0.70 |
| MACD | -0.26 | -0.10 |
| Stochastic Oscillator | 24.92 | 54.68 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.